Clinical trial Recruiting at 1 site Observational

Thailand ALS Patient Registry

Official title: A Prospective, Multicenter Registry Study of Amyotrophic Lateral Sclerosis in Thailand

Run by Chulalongkorn University · NCT07175935 · Data updated 2026-11-12

This registry will collect detailed clinical, genetic, and outcome information from adults with ALS across Thailand to track disease progression and treatment results.

Quick facts

Study typeObservational
SexAll
Enrollment100 (estimated)
SponsorChulalongkorn University
Academic / other
Locations1 site (Pathum Wan, Bangkok)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedSeptember 16, 2025
Trial IDNCT07175935 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) with a diagnosis of ALS by El Escorial or Gold Coast criteria who are willing and able to provide informed consent and receive care at participating Thai centers are ideal candidates.

Probably not a fit

Patients who decline consent, who have alternative diagnoses that mimic ALS, or who expect direct access to experimental treatments should not expect clinical benefit from registry participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, observational, multicenter registry will enroll adults diagnosed with ALS at major academic hospitals and neuromuscular centers in Thailand and follow them longitudinally using standardized assessments. Data collected will include ALSFRS-R scores, staging systems (King, MiTos, 9-point), motor and respiratory function tests, quality-of-life measures, cognitive and behavioral evaluations, genetic profiles, and treatments received. All data will be entered into a secure REDCap database with protections under Thai PDPA and international standards. No experimental interventions are provided; the registry is intended to define epidemiology and natural history and to serve as a platform for future clinical and translational research.

Why it matters

Potential benefit: If successful, the registry could improve understanding of ALS in Thailand, help optimize patient care, and make it easier to run future clinical trials locally.

How similar studies have gone: National and international ALS registries have previously yielded important epidemiological, genetic, and natural-history insights, so the registry approach is established though large-scale Thai data are currently lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of ALS according to El Escorial or Gold Coast criteria
* Age ≥ 18 years
* Ability and willingness to provide informed consent

Exclusion Criteria:

* Patients unwilling to provide informed consent
* Patients with alternative diagnoses mimicking ALS

Where it's running

  • King Chulalongkorn Memorial hospital, The Thai Red Cross Society
    Pathum Wan, Bangkok, Thailand
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.